Evaluation of a multi-functional nanocarrier for targeted breast cancer iNOS gene therapy

International Journal of Pharmaceutics

Volumn 405, Issue 1-2, 2011, Pages 196-202

  McCarthy, Helen O ^a   Zholobenko, Alek V ^a   Wang, Yuhua ^b   Canine, Brenda ^b   Robson, Tracy ^a   Hirst, David G ^a   Hatefi, Arash ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

Breast cancer; Designer biomimetic vector; Gene therapy; iNOS

Indexed keywords

DESIGNER BIOMIMETIC VECTOR; HYBRID PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NANOCARRIER; NANOPARTICLE; NITRITE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BYSTANDER EFFECT; CANCER GENE THERAPY; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG TARGETING; EVALUATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIGHT SCATTERING; PARTICLE SIZE; PRIORITY JOURNAL; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; NANOPARTICLES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PARTICLE SIZE; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 79151469679     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.11.051     Document Type: Article

References (35)

1. E. Ambegia, S. Ansell, P. Cullis, J. Heyes, L. Palmer, and I. MacLachlan Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression Biochim. Biophys. Acta 1669 2005 155 163
2. C.M. Bagi Targeting of therapeutic agents to bone to treat metastatic cancer Adv. Drug. Deliv. Rev. 20 2005 995 1010
3. A.W. Cochrane, A. Perkins, and C.A. Rosen Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function J. Virol. 64 1990 881 885
4. J.A. Coulter, H.O. McCarthy, J. Worthington, T. Robson, S. Scott, and D.G. Hirst The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation Gene Ther. 7 2008 495 503
5. K.Y. Dane, L.A. Chan, J.J. Rice, and P.S. Daugherty Isolation of cell specific peptide ligands using fluorescent bacterial display libraries J. Immunol. Methods 309 2006 120 129
6. M. De Ridder, D. Verellen, V. Verovski, and G. Storme Hypoxic tumor cell radiosensitization through nitric oxide Nitric Oxide 19 2008 164 169
7. J.M. Escoffre, J. Teissié, and M.P. Rols Gene transfer: how can the biological barriers be overcome? J. Membr. Biol. 236 2010 61 74
8. R.J. Griffin, C.M. Makepeace, W.J. Hur, and C.W. Song Radiosensitization of hypoxic tumor cells in vitro by nitric oxide Int. J. Radiat. Oncol. Biol. Phys. 36 1996 377 383
9. J.R. Halliwill, C.T. Minson, and M.J. Joyner Effect of systemic nitric oxide synthase inhibition on postexercise hypotension in humans J. Appl. Physiol. 89 2000 1830 1836
10. M.L. Hammarskjold, J. Heimer, B. Hammarskjold, I. Sangwan, L. Albert, and D. Rekosh Regulation of human immunodeficiency virus env expression by the rev gene product J. Virol. 63 1989 1959 1966
11. T. Ishida, M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, E. Majima, and H. Kiwada Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes J. Control Release 112 2006 15 25
12. M. Keller, T. Tagawa, M. Preuss, and A.D. Miller Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu Biochemistry 41 2002 652 659
13. P.K. Kim, R. Zamora, P. Petrosko, and T.R. Billiar The regulatory role of nitric oxide in apoptosis Int. Immunopharmacol. 1 2001 1421 1441
14. S. Levy, B. Zhou, N. Ballian, Z. Li, S.H. Liu, M. Feanny, X.P. Wang, D.K. Blanchard, and F.C. Brunicardi Cytotoxic gene therapy for human breast cancer in vitro J. Surg. Res. 136 2006 154 160
15. H. Lv, S. Zhang, B. Wang, S. Cui, and J. Yan Toxicity of cationic lipids and cationic polymers in gene delivery J. Control Release 114 2006 100 109
16. M.H. Malim, J. Hauber, S.Y. Le, J.V. Maizel, and B.R. Cullen The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA Nature 338 1989 254 257
17. S.S. Mangipudi, B.F. Canine, Y. Wang, and A. Hatefi Development of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells.Mol Pharmacology 6 2009 1100 1109
18. H.O. McCarthy, J. Worthington, E. Barrett, E. Cosimo, M. Boyd, R.J. Mairs, C. Ward, S.R. McKeown, D.G. Hirst, and T. Robson p21((WAF1))-mediated transcriptional targeting of inducible nitric oxide synthase gene therapy sensitizes tumours to fractionated radiotherapy Gene Ther. 3 2007 246 255
19. H.O. McCarthy, J.A. Coulter, J. Worthington, T. Robson, and D.G. Hirst Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer J. Gene Med. 9 2007 511 520
20. P. Midoux, A. Kichler, V. Boutin, J.C. Maurizot, and M. Monsigny Membrane permeabilization and efficient gene transfer by a peptide containing several histidines Bioconjug. Chem. 9 1998 260 267
21. K.D. Murray, C.J. Etheridge, S.I. Shah, D.A. Matthews, W. Russell, H.M. Gurling, and A.D. Miller Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core Gene Ther. 8 2001 453 460
22. S. Porasuphatana, P. Tsai, and G.M. Rosen The generation of free radicals by nitric oxide synthase Comp.Biochem. Physiol. C: Toxicol. Pharmacol. 134 2003 281 289
23. J.J. Shacka, M.A. Sahawneh, J.D. Gonzalez, Y.Z. Ye, T.L. D'Alessandro, and A.G. Estévez Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells Cell Death Differ. 13 2006 1506 1514
24. O. Sidorkina, M.G. Espey, K.M. Miranda, D.A. Wink, and J. Laval Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species Free Radic. Biol. Med. 35 2003 1431 1438
25. C. Szabó, and H. Ohshima DNA damage induced by peroxynitrite: subsequent biological effects Nitric Oxide 1 2003 373 385
26. J.R. Viola, S. El-Andaloussi, L.L. Oprea, and C.I. Smith Non-viral nanovectors for gene delivery: factors that govern successful therapeutics Exp. Opin Drug Deliv. 7 2010 721 735
27. D. Wang, J. Wei, K. Hsu, J. Jau, M.W. Lieu, T.J. Chao, and H.I. Chen Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats J. Biomed. Sci. 6 1999 28 35
28. Z. Wang, T. Cook, S. Alber, K. Liu, I. Kovesdi, S.K. Watkins, Y. Vodovotz, T.R. Billiar, and D. Blumberg Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumour vascularity Cancer Res. 64 2004 1386 1395
29. D.A. Wink, and J. Laval The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo Carcinogenesis 15 1994 2125 2129
30. D.A. Wink, Y. Vodovotz, J.A. Cook, M.C. Krishna, S. Kim, D. Coffin, W. DeGraff, A.M. Deluca, J. Liebmann, and J.B. Mitchell The role of nitric oxide chemistry in cancer treatment Biochemistry 63 1998 802 809
31. J. Worthington, T. Robson, M. O'Keeffe, and D.G. Hirst Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy Gene Ther. 9 2002 263 269
32. J. Worthington, H.O. McCarthy, E. Barrett, C. Adams, T. Robson, and D.G. Hirst Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment J. Gene Med. 6 2004 673 680
33. J. Worthington, T. Robson, S. Scott, and D.G. Hirst Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer Gene Ther. 12 2005 1417 1423
34. K. Xie, S. Huang, Z. Dong, S.H. Juang, M. Gutman, Q.W. Xie, C. Nathan, and I.L. Fidler Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells J. Exp. Med. 181 1995 1333 1343
35. K. Xie, and I.J. Fidler Therapy of cancer metastasis by activation of the inducible nitric oxide synthase Cancer Metast. Rev. 17 1998 55 75